rss
BMJ Case Reports 2018; doi:10.1136/bcr-2018-225989
  • Rare disease
  • CASE REPORT

Long-term survival in a patient with pulmonary spindle cell carcinoma treated with traditional Chinese medicine

Open Access
  1. Yuanhong Zhao2
  1. 1Department of Breast Oncology, Tianjin Tumor Hospital, Tianjin, China
  2. 2Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
  1. Correspondence to Professor Yuanhong Zhao, yuanhongzh98{at}163.com
  • Accepted 13 August 2018
  • Published 8 September 2018

Summary

Spindle cell carcinoma (SCC) is a rare pulmonary malignancy, accounting for only 0.2%–0.3% of all lung cancers. Therefore, the prognosis and treatment of pulmonary SCC is unclear. There are only 13 reported cases in literature, only three of which had a survival of more than 11 months. Here we reported a long-term survival of a patient with pulmonary SCC who underwent treatment with traditional Chinese medicine. At the most recent follow-up in July 2018, her survival after diagnosis is 48 months and she continues to do well. To our knowledge, this is the longest survival of late stage SCC with the largest tumour burden.

Footnotes

  • Contributors WL summarised the case presentation and completed the manuscript. MC collected the patient’s information and clinical data. YZ prescribed the patient with TCM therapy and provided all the TCM theory support.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Open Access

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article